"10.1371_journal.pone.0112159","plos one","2014-11-11T00:00:00Z","Lien Tembuyser; VÃ©ronique Tack; Karen Zwaenepoel; Patrick Pauwels; Keith Miller; Lukas Bubendorf; Keith Kerr; Ed Schuuring; Erik Thunnissen; Elisabeth M C Dequeker","Department of Public Health and Primary Care, Biomedical Quality Assurance Research Unit, KU Leuven â€ University of Leuven, Leuven, Belgium; Department of Pathology, Antwerp University Hospital, Edegem, Belgium; UK NEQAS ICC & ISH, London, United Kingdom; Institute for Pathology, Basel University Hospital, Basel, Switzerland; Department of Pathology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom; Department of Pathology and Medical Biology, University of Groningen, Groningen, the Netherlands; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands","Conceived and designed the experiments: LT KM ES ET ED. Performed the experiments: LT KM ES ET ED. Analyzed the data: LT VT KZ PP KK KM LB ES ET ED. Contributed reagents/materials/analysis tools: LT KM ES ET ED. Contributed to the writing of the manuscript: LT VT PP KZ ED.","Patrick Pauwels received a scientific grant from Pfizer and receives occasional speaker fees from Pfizer, Ventana (Roche) and Abbott. Lukas Bubendorf receives consultation and lecture fees from Roche and Pfizer. Keith Kerr receives consultation and lecture fees from Pfizer, Novartis and Abbott. Ed Schuuring has board membership (Roche, Pfizer and Novartis) and receives lecture fees (Roche and Abbott). Erik Thunnissen received an unrestricted grant from Pfizer and travel and speakerâ€™s fee for presentation (Pfizer). Elisabeth M. C. Dequeker received an unrestricted grant from Pfizer and remuneration from AstraZeneca. The other authors have no competing interests to declare. The competing interests of the authors of this manuscript do not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2014","11","Lien Tembuyser","LT",10,FALSE,5,5,10,NA,TRUE,TRUE,FALSE,0,NA,FALSE
